Literature DB >> 9454695

Identification of conserved hydrophobic C-terminal residues of the human papillomavirus type 1 E1E4 protein necessary for E4 oligomerisation in vivo.

I Ashmole1, P H Gallimore, S Roberts.   

Abstract

Previous studies have shown that human papillomavirus (HPV) E4 proteins undergo oligomerisation, although the precise sequences involved have not been identified. Using the yeast two-hybrid system we have identified HPV 1 E4 sequences that are critical to multimerisation. Fusion proteins were created by linking wild-type and mutant E4 proteins to a LexA DNA-binding domain or a B42 transactivation domain. HPV 1 E4:E4 interactions were examined by expression of these fusion proteins in Saccharomyces cerevisiae. This assay showed that (1) amino acid residues 95 to 115 at the carboxy-terminus were critical for oligomerisation and (2) hydrophobic residues (isoleucine 107, phenylalanine 114) in this domain are major determinants in the formation of oligomers. Interestingly, the carboxy-terminal domain shares homology with other E4 proteins of cutaneous HPV types and, furthermore, positions 107 and 114 are conserved residues. Substitution of the conserved aspartate amino acids (residues 110 and 112) did not abrogate E4 oligomerisation. Chemical cross-linking of wart and recombinant (baculovirus-expressed) HPV 1 E4 protein indicated that in solution this viral protein forms complexes consistent in size with either trimers or tetramers. These complexes were resistant to urea denaturation and are not dependent on the formation of disulphide linkages. A mutant protein containing a deletion of residues 110 to 115 was unable to form oligomers following cross-linking supporting a role for this region in mediating E4:E4 interactions. We conclude that oligomerisation of the HPV 1 E4 protein is likely to be mediated by carboxy-terminal residues and that conserved hydrophobic residues of this domain play a major role in E4 oligomerisation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9454695     DOI: 10.1006/viro.1997.8909

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  7 in total

1.  The ND10 component promyelocytic leukemia protein relocates to human papillomavirus type 1 E4 intranuclear inclusion bodies in cultured keratinocytes and in warts.

Authors:  Sally Roberts; Michele L Hillman; Gillian L Knight; Phillip H Gallimore
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

2.  Cooperation between different forms of the human papillomavirus type 1 E4 protein to block cell cycle progression and cellular DNA synthesis.

Authors:  Gillian L Knight; John R Grainger; Phillip H Gallimore; Sally Roberts
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

3.  Role for Wee1 in inhibition of G2-to-M transition through the cooperation of distinct human papillomavirus type 1 E4 proteins.

Authors:  Gillian L Knight; Andrew S Turnell; Sally Roberts
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

4.  The E1circumflexE4 protein of human papillomavirus interacts with the serine-arginine-specific protein kinase SRPK1.

Authors:  Ian Bell; Ashley Martin; Sally Roberts
Journal:  J Virol       Date:  2007-03-14       Impact factor: 5.103

5.  The E1E4 protein of human papillomavirus type 16 associates with a putative RNA helicase through sequences in its C terminus.

Authors:  J Doorbar; R C Elston; S Napthine; K Raj; E Medcalf; D Jackson; N Coleman; H M Griffin; P Masterson; S Stacey; Y Mengistu; J Dunlop
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

6.  Functional analysis of the human papillomavirus type 16 E1=E4 protein provides a mechanism for in vivo and in vitro keratin filament reorganization.

Authors:  Qian Wang; Heather Griffin; Shirley Southern; Deborah Jackson; Ana Martin; Pauline McIntosh; Clare Davy; Phillip J Masterson; Philip A Walker; Peter Laskey; M Bishr Omary; John Doorbar
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

7.  Life cycle heterogeneity in animal models of human papillomavirus-associated disease.

Authors:  Woei Ling Peh; Kate Middleton; Neil Christensen; Philip Nicholls; Kiyofumi Egawa; Karl Sotlar; Janet Brandsma; Alan Percival; Jon Lewis; Wen Jun Liu; John Doorbar
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.